Respiratory syncytial virus-induced pulmonary disease and exacerbation of allergic asthma

Contributions to Microbiology

Volumn 14, Issue , 2007, Pages 68-82

  Lukacs, N ^a,b   Smit, J ^a   Lindell, D ^a   Schaller, M ^a  

^a UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^b NONE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

RESPIRATORY SYNCYTIAL VIRUS; RICE STRIPE VIRUS;

CHEMOKINE; TOLL LIKE RECEPTOR;

ANIMAL; ASTHMA; DENDRITIC CELL; DISEASE MODEL; HUMAN; IMMUNOLOGY; INNATE IMMUNITY; MOUSE; MUCUS; RESPIRATORY SYNCYTIAL PNEUMOVIRUS; REVIEW; VIROLOGY; VIRUS INFECTION;

ANIMALS; ASTHMA; CHEMOKINES; DENDRITIC CELLS; DISEASE MODELS, ANIMAL; HUMANS; IMMUNITY, NATURAL; MICE; MUCUS; RESPIRATORY SYNCYTIAL VIRUS INFECTIONS; RESPIRATORY SYNCYTIAL VIRUSES; TOLL-LIKE RECEPTORS;

EID: 35848951868     PISSN: 14209519     EISSN: 1662291X     Source Type: Book Series    
DOI: 10.1159/000107055     Document Type: Review

References (121)

1. Busse WW, Gern JE, Dick EC: The role of respiratory viruses in asthma. Ciba Found Symp 1997;206:208-219.
2. Stempel DA, Boucher RC: Respiratory infection and airway reactivity. Med Clin North Am 1981;65:1045-1053.
3. Hogg JC: Childhood viral infection and the pathogenesis of asthma and chronic obstructive lung disease. Am J Respir Crit Care Med 1999;160:S26-S28.
4. Holtzman MJ, Morton JD, Shornick LP, Tyner JW, O'Sullivan MP, Antao A, Lo M, Castro M, Walter MJ: Immunity, inflammation, and remodeling in the airway epithelial barrier: epithelialviral-allergic paradigm. Physiol Rev 2002;82:19-46.
5. Nicholson KG, Kent J, Ireland DC: Respiratory viruses and exacerbations of asthma in adults. BMJ 1993;307:982-986.
6. Zhao J, Takamura M, Yamaoka A, Odajima Y, Iikura Y: Altered eosinophil levels as a result of viral infection in asthma exacerbation in childhood. Pediatr Allergy Immunol 2002;13:47-50.
7. Simpson JL, Moric I, Wark PA, Johnston SL, Gibson PG: Use of induced sputum for the diagnosis of influenza and infections in asthma: a comparison of diagnostic techniques. J Clin Virol 2003;26:339-346.
8. Schlesinger C, Koss MN: Bronchiolitis: update 2001. Curr Opin Pulm Med 2002;8:112-116.
9. Panitch HB: Bronchiolitis in infants. Curr Opin Pediatr 2001;13:256-260.
10. Openshaw PJ, Dean GS, Culley FJ: Links between respiratory syncytial virus bronchiolitis and childhood asthma: clinical and research approaches. Pediatr Infect Dis J 2003;22:S58-S65.
11. Welliver RC: Respiratory syncytial virus and other respiratory viruses. Pediatr Infect Dis J 2003;22:S6-S12.
12. Welliver RC: Review of epidemiology and clinical risk factors for severe respiratory syncytial virus (RSV) infection. J Pediatr 2003;143:S112-S117.
13. Black CP: Systematic review of the biology and medical management of respiratory syncytial virus infection. Respir Care 2003;48:209-233.
14. Stensballe LG, Devasundaram JK, Simoes EA: Respiratory syncytial virus epidemics: the ups and downs of a seasonal virus. Pediatr Infect Dis J 2003;22:S21-S32.
15. CDC: Brief report: respiratory syncytial virus activity - United States, 2004-2005. MMWR Morb Mortal Wkly Rep 2005;54:1259-1260.
16. Thompson WW, Shay DK, Weintraub E, Brammer L, Cox N, Anderson LJ, Fukuda K: Mortality associated with influenza and respiratory syncytial virus in the United States. JAMA 2003;289:179-186.
17. CDC: Respiratory syncytial virus activity - United States, 2000-01 season. MMWR Morb Mortal Wkly Rep 2002;51:26-28.
18. CDC: Respiratory syncytial virus activity - United States, 1999-2000 season. MMWR Morb Mortal Wkly Rep 2000;49:1091-1093.
19. CDC: Update: respiratory syncytial virus activity - United States, 1998-1999 season. MMWR Morb Mortal Wkly Rep 1999;48:1104-1106, 1115.
20. CDC: Update: respiratory syncytial virus activity - United States, 1997-98 season. MMWR Morb Mortal Wkly Rep 1997;46:1163-1165.
21. Waris ME, Tsou C, Erdman DD, Zaki SR, Anderson LJ: Respiratory synctial virus infection in BALB/c mice previously immunized with formalin-inactivated virus induces enhanced pulmonary inflammatory response with a predominant Th2-like cytokine pattern. J Virol 1996;70:2852-2860.
22. Dudas RA, Karron RA: Respiratory syncytial virus vaccines. Clin Microbiol Rev 1998;11:430-439.
23. Crowcroft NS, Cutts F, Zambon MC: Respiratory syncytial virus: an underestimated cause of respiratory infection, with prospects for a vaccine. Commun Dis Public Health 1999;2:234-241.
24. Lemanske RF Jr: The childhood origins of asthma (COAST) study. Pediatr Allergy Immunol 2002;13(suppl 15):38-43.
25. Graham BS, Johnson TR, Peebles RS: Immune-mediated disease pathogenesis in respiratory syncytial virus infection. Immunopharmacology 2000;48:237-247.
26. Hussell T, Openshaw PJ: IL-12-activated NK cells reduce lung eosinophilia to the attachment protein of respiratory syncytial virus but do not enhance the severity of illness in CD8 T cell-immunodeficient conditions. J Immunol 2000;165:7109-7115.
27. Fawaz LM, Sharif-Askari E, Menezes J: Up-regulation of NK cytotoxic activity via IL-15 induction by different viruses: a comparative study. J Immunol 1999;163:4473-4480.
28. Chang J, Srikiatkhachorn A, Braciale TJ: Visualization and characterization of respiratory syncytial virus F-specific CD8(+) T cells during experimental virus infection. J Immunol 2001;167:4254-4260.
29. Mbawuike IN, Wells J, Byrd R, Cron SG, Glezen WP, Piedra PA: HLA-restricted CD8+ cytotoxic T lymphocyte, interferon-gamma, and interleukin-4 responses to respiratory syncytial virus infection in infants and children. J Infect Dis 2001;183:687-696.
30. Aung S, Tang YW, Graham BS: Interleukin-4 diminishes CD8(+) respiratory syncytial virus-specific cytotoxic T-lymphocyte activity in vivo. J Virol 1999;73:8944-8949.
31. Tripp RA, Moore D, Jones L, Sullender W, Winter J, Anderson LJ: Respiratory syncytial virus G and/or SH protein alters Th1 cytokines, natural killer cells, and neutrophils responding to pulmonary infection in BALB/c mice. J Virol 1999;73:7099-7107.
32. Chang J, Braciale TJ: Respiratory syncytial virus infection suppresses lung CD8+ T-cell effector activity and peripheral CD8+ T-cell memory in the respiratory tract. Nat Med 2002;8:54-60.
33. Chang J, Choi SY, Jin HT, Sung YC, Braciale TJ: Improved effector activity and memory CD8 T cell development by IL-2 expression during experimental respiratory syncytial virus infection. J Immunol 2004;172:503-508.
34. Boyton RJ, Openshaw PJ: Pulmonary defences to acute respiratory infection. Br Med Bull 2002;61:1-12.
35. Price JF: Acute and long-term effects of viral bronchiolitis in infancy. Lung 1990;168(suppl):414-421.
36. McBride JT: Pulmonary function changes in children after respiratory syncytial virus infection in infancy. J Pediatr 1999;135:28-32.
37. Prince AM, Jacobs RF: Prevention of respiratory syncytial virus infection in high risk infants. J Ark Med Soc 2001;98:115-118.
38. Teixeira MM, Almeida IC, Gazzinelli RT: Introduction: innate recognition of bacteria and protozoan parasites. Microbes Infect 2002;4:883-886.
39. Philpott DJ, Girardin SE: The role of Toll-like receptors and Nod proteins in bacterial infection. Mol Immunol 2004;41:1099-1108.
40. Akira S, Hemmi H: Recognition of pathogen-associated molecular patterns by TLR family. Immunol Lett 2003;85:85-95.
41. Sandor F, Buc M: Toll-like receptors. I. Structure, function and their ligands. Folia Biol (Praha) 2005;51:148-157.
42. Roeder A, Kirschning CJ, Rupec RA, Schaller M, Weindl G, Korting HC: Toll-like receptors as key mediators in innate antifungal immunity. Med Mycol 2004;42:485-498.
43. Haynes LM, Moore DD, Kurt-Jones EA, Finberg RW, Anderson LJ, Tripp RA: Involvement of toll-like receptor 4 in innate immunity to respiratory syncytial virus. J Virol 2001;75:10730-10737.
44. Haeberle HA, Takizawa R, Casola A, Brasier AR, Dieterich HJ, Van Rooijen N, Gatalica Z, Garofalo RP: Respiratory syncytial virus-induced activation of nuclear factor-kappaB in the lung involves alveolar macrophages and toll-like receptor 4-dependent pathways. J Infect Dis 2002;186:1199-1206.
45. Rallabhandi P, Bell J, Boukhvalova MS, Medvedev A, Lorenz E, Arditi M, Hemming VG, Blanco JC, Segal DM, Vogel SN: Analysis of TLR4 polymorphic variants: new insights into TLR4/MD-2/CD14 stoichiometry, structure, and signaling. J Immunol 2006;177:322-332.
46. Kadowaki N, Ho S, Antonenko S, Malefyt RW, Kastelein RA, Bazan F, Liu YJ: Subsets of human dendritic cell precursors express different toll-like receptors and respond to different microbial antigens. J Exp Med 2001;194:863-869.
47. Spisek R, Bretaudeau L, Barbieux I, Meflah K, Gregoire M: Standardized generation of fully mature p70 IL-12 secreting monocyte-derived dendritic cells for clinical use. Cancer Immunol Immunother 2001;50:417-427.
48. Rudd BD, Smit JJ, Flavell RA, Alexopoulou L, Schaller MA, Gruber A, Berlin AA, Lukacs NW: Deletion of TLR3 alters the pulmonary immune environment and mucus production during respiratory syncytial virus infection. J Immunol 2006;176:1937-1942.
49. Diebold SS, Kaisho T, Hemmi H, Akira S, Reis e Sousa C: Innate antiviral responses by means of TLR7-mediated recognition of single-stranded RNA. Science 2004;303:1529-1531.
50. Heil F, Hemmi H, Hochrein H, Ampenberger F, Kirschning C, Akira S, Lipford G, Wagner H, Bauer S: Species-specific recognition of single-stranded RNA via toll-like receptor 7 and 8. Science 2004;303:1526-1529.
51. Lund JM, Alexopoulou L, Sato A, Karow M, Adams NC, Gale NW, Iwasaki A, Flavell RA: Recognition of single-stranded RNA viruses by Toll-like receptor 7. Proc Natl Acad Sci USA 2004;101:5598-5603.
52. Yoneyama M, Kikuchi M, Natsukawa T, Shinobu N, Imaizumi T, Miyagishi M, Taira K, Akira S, Fujita T: The RNA helicase RIG-I has an essential function in double-stranded RNA-induced innate antiviral responses. Nat Immunol 2004;5:730-737.
53. Blanco-Quiros A, Gonzalez H, Arranz E, Lapena S: Decreased interleukin-12 levels in umbilical cord blood in children who developed acute bronchiolitis. Pediatr Pulmonol 1999;28:175-180.
54. Bloom ET, Horvath JA: Cellular and molecular mechanisms of the IL-12-induced increase in allospecific murine cytolytic T cell activity. Implications for the age-related decline in CTL. J Immunol 1994;152:4242-4254.
55. Chehimi J, Valiante NM, D'Andrea A, Rengaraju M, Rosado Z, Kobayashi M, Perussia B, Wolf SF, Starr SE, Trinchieri G: Enhancing effect of natural killer cell stimulatory factor (NKSF/interleukin-12) on cell-mediated cytotoxicity against tumor-derived and virus-infected cells. Eur J Immunol 1993;23:1826-1830.
56. Orange JS, Wolf SF, Biron CA: Effects of IL-12 on the response and susceptibility to experimental viral infections. J Immunol 1994;152:1253-1264.
57. Moller GM, Overbeek SE, Van Helden-Meeuwsen CG, Van Haarst JM, Prens EP, Mulder PG, Postma DS, Hoogsteden HC: Increased numbers of dendritic cells in the bronchial mucosa of atopic asthmatic patients: downregulation by inhaled corticosteroids. Clin Exp Allergy 1996;26:517-524.
58. Jahnsen FL, Moloney ED, Hogan T, Upham JW, Burke CM, Holt PG: Rapid dendritic cell recruitment to the bronchial mucosa of patients with atopic asthma in response to local allergen challenge. Thorax 2001;56:823-826.
59. Lambrecht BN, Salomon B, Klatzmann D, Pauwels RA: Dendritic cells are required for the development of chronic eosinophilic airway inflammation in response to inhaled antigen in sensitized mice. J Immunol 1998;160:4090-4097.
60. Webb TJ, Sumpter TL, Thiele AT, Swanson KA, Wilkes DS: The phenotype and function of lung dendritic cells. Crit Rev Immunol 2005;25:465-491.
61. Julia V, Hessel EM, Malherbe L, Glaichenhaus N, O'Garra A, Coffman RL: A restricted subset of dendritic cells captures airborne antigens and remains able to activate specific T cells long after antigen exposure. Immunity 2002;16:271-283.
62. de Heer HJ, Hammad H, Soullie T, Hijdra D, Vos N, Willart MA, Hoogsteden HC, Lambrecht BN: Essential role of lung plasmacytoid dendritic cells in preventing asthmatic reactions to harmless inhaled antigen. J Exp Med 2004;200:89-98.
63. Yoneyama H, Matsuno K, Toda E, Nishiwaki T, Matsuo N, Nakano A, Narumi S, Lu B, Gerard C, Ishikawa S, Matsushima K: Plasmacytoid DCs help lymph node DCs to induce anti-HSV CTLs. J Exp Med 2005;202:425-435.
64. Megjugorac NJ, Young HA, Amrute SB, Olshalsky SL, Fitzgerald-Bocarsly P: Virally stimulated plasmacytoid dendritic cells produce chemokines and induce migration of T and NK cells. J Leukoc Biol 2004;75:504-514.
65. Kohrgruber N, Groger M, Meraner P, Kriehuber E, Petzelbauer P, Brandt S, Stingl G, Rot A, Maurer D: Plasmacytoid dendritic cell recruitment by immobilized CXCR3 ligands. J Immunol 2004;173:6592-6602.
66. Hochrein H, Schlatter B, O'Keeffe M, Wagner C, Schmitz F, Schiemann M, Bauer S, Suter M, Wagner H: Herpes simplex virus type-1 induces IFN-alpha production via Toll-like receptor 9-dependent and -independent pathways. Proc Natl Acad Sci USA 2004;101:11416-11421.
67. Tripp RA, Moore D, Anderson LJ: TH(1)- and TH(2)-TYPE cytokine expression by activated t lymphocytes from the lung and spleen during the inflammatory response to respiratory syncytial virus. Cytokine 2000;12:801-807.
68. Bartz H, Buning-Pfaue F, Turkel O, Schauer U: Respiratory syncytial virus induces prostaglandin E2, IL-10 and IL-11 generation in antigen presenting cells. Clin Exp Immunol 2002;129:438-445.
69. Bartz H, Turkel O, Hoffjan S, Rothoeft T, Gonschorek A, Schauer U: Respiratory syncytial virus decreases the capacity of myeloid dendritic cells to induce interferon-gamma in naive T cells. Immunology 2003;109:49-57.
70. Kondo Y, Matsuse H, Machida I, Kawano T, Saeki S, Tomari S, Obase Y, Fukushima C, Kohno S: Regulation of mite allergen-pulsed murine dendritic cells by respiratory syncytial virus. Am J Respir Crit Care Med 2004;169:494-498.
71. de Graaff PM, de Jong EC, van Capel TM, van Dijk ME, Roholl PJ, Boes J, Luytjes W, Kimpen JL, van Bleek GM: Respiratory syncytial virus infection of monocyte-derived dendritic cells decreases their capacity to activate CD4 T cells. J Immunol 2005;175:5904-5911.
72. Smit JJ, Rudd BD, Lukacs NW: Plasmacytoid dendritic cells inhibit pulmonary immunopathology and promote clearance of respiratory syncytial virus. J Exp Med 2006;203:1153-1159.
73. Gill MA, Palucka AK, Barton T, Ghaffar F, Jafri H, Banchereau J, Ramilo O: Mobilization of plasmacytoid and myeloid dendritic cells to mucosal sites in children with respiratory syncytial virus and other viral respiratory infections. J Infect Dis 2005;191:1105-1115.
74. Ito T, Wang YH, Liu YJ: Plasmacytoid dendritic cell precursors/type I interferon-producing cells sense viral infection by Toll-like receptor (TLR) 7 and TLR9. Springer Semin Immunopathol 2005;26:221-229.
75. Bonville CA, Rosenberg HF, Domachowske JB: Macrophage inflammatory protein-1alpha and RANTES are present in nasal secretions during ongoing upper respiratory tract infection. Pediatr Allergy Immunol 1999;10:39-44.
76. Abu-Harb M, Bell F, Finn A, Rao WH, Nixon L, Shale D, Everard ML: IL-8 and neutrophil elastase levels in the respiratory tract of infants with RSV bronchiolitis. Eur Respir J 1999;14:139-143.
77. Gern JE, Martin MS, Anklam KA, Shen K, Roberg KA, Carlson-Dakes KT, Adler K, Gilbertson-White S, Hamilton R, Shult PA, Kirk CJ, Da Silva DF, Sund SA, Kosorok MR, Lemanske RF Jr: Relationships among specific viral pathogens, virus-induced interleukin-8, and respiratory symptoms in infancy. Pediatr Allergy Immunol 2002;13:386-393.
78. Matsuda K, Tsutsumi H, Sone S, Yoto Y, Oya K, Okamoto Y, Ogra PL, Chiba S: Characteristics of IL-6 and TNF-alpha production by respiratory syncytial virus-infected macrophages in the neonate. J Med Virol 1996;48:199-203.
79. Panuska JR, Merolla R, Rebert NA, Hoffmann SP, Tsivitse P, Cirino NM, Silverman RH, Rankin JA: Respiratory syncytial virus induces interleukin-10 by human alveolar macrophages. Suppression of early cytokine production and implications for incomplete immunity. J Clin Invest 1995;96:2445-2453.
80. Becker S, Quay J, Soukup J: Cytokine (tumor necrosis factor, IL-6, and IL-8) production by respiratory syncytial virus-infected human alveolar macrophages. J Immunol 1991;147:4307-4312.
81. Midulla F, Huang YT, Gilbert IA, Cirino NM, McFadden ER Jr, Panuska JR: Respiratory syncytial virus infection of human cord and adult blood monocytes and alveolar macrophages. Am Rev Respir Dis 1989;140:771-777.
82. Becker S, Reed W, Henderson FW, Noah TL: RSV infection of human airway epithelial cells causes production of the beta-chemokine RANTES. Am J Physiol 1997;272:L512-L520.
83. Olszewska-Pazdrak B, Casola A, Saito T, Alam R, Crowe SE, Mei F, Ogra PL, Garofalo RP: Cell-specific expression of RANTES, MCP-1, and MIP-1alpha by lower airway epithelial cells and eosinophils infected with respiratory syncytial virus. J Virol 1998;72:4756-4764.
84. Saito T, Deskin RW, Casola A, Haeberle H, Olszewska B, Ernst PB, Alam R, Ogra PL, Garofalo R: Respiratory syncytial virus induces selective production of the chemokine RANTES by upper airway epithelial cells. J Infect Dis 1997;175:497-504.
85. Mastronarde JG, He B, Monick MM, Mukaida N, Matsushima K, Hunninghake GW: Induction of interleukin (IL)-8 gene expression by respiratory syncytial virus involves activation of nuclear factor (NF)-kappa B and NF-IL-6. J Infect Dis 1996;174:262-267.
86. Noah TL, Becker S: Chemokines in nasal secretions of normal adults experimentally infected with respiratory syncytial virus. Clin Immunol 2000;97:43-49.
87. Garofalo RP, Patti J, Hintz KA, Hill V, Ogra PL, Welliver RC: Macrophage inflammatory protein-1 alpha (not T helper type 2 cytokines) is associated with severe forms of respiratory syncytial virus bronchiolitis. J Infect Dis 2001;184:393-399.
88. Domachowske JB, Bonville CA, Gao JL, Murphy PM, Easton AJ, Rosenberg HF: MIP-1alpha is produced but it does not control pulmonary inflammation in response to respiratory syncytial virus infection in mice. Cell Immunol 2000;206:1-6.
89. John AE, Berlin AA, Lukacs NW: Respiratory syncytial virus-induced CCL5/RANTES contributes to exacerbation of allergic airway inflammation. Eur J Immunol 2003;33:1677-1685.
90. Tekkanat KK, Maassab H, Miller A, Berlin AA, Kunkel SL, Lukacs NW: RANTES (CCL5) production during primary respiratory syncytial virus infection exacerbates airway disease. Eur J Immunol 2002;32:3276-3284.
91. Miller AL, Strieter RM, Gruber AD, Ho SB, Lukacs NW: CXCR2 regulates respiratory syncytial virus-induced airway hyperreactivity and mucus overproduction. J Immunol 2003;170:3348-3356.
92. Haeberle HA, Kuziel WA, Dieterich HJ, Casola A, Gatalica Z, Garofalo RP: Inducible expression of inflammatory chemokines in respiratory syncytial virus-infected mice: role of MIP-1alpha in lung pathology. J Virol 2001;75:878-890.
93. Tripp RA, Jones L, Anderson LJ: Respiratory syncytial virus G and/or SH glycoproteins modify CC and CXC chemokine mRNA expression in the BALB/c mouse. J Virol 2000;74:6227-6229.
94. Miller AL, Bowlin TL, Lukacs NW: Respiratory syncytial virus-induced chemokine production: linking viral replication to chemokine production in vitro and in vivo. J Infect Dis 2004;189:1419-1430.
95. Thomas MS, Kunkel SL, Lukacs NW: Differential role of IFN-gamma-inducible protein 10 kDa in a cockroach antigen-induced model of allergic airway hyperreactivity: systemic versus local effects. J Immunol 2002;169:7045-7053.
96. Bochner BS, Hudson SA, Xiao HQ, Liu MC: Release of both CCR4-active and CXCR3-active chemokines during human allergic pulmonary late-phase reactions. J Allergy Clin Immunol 2003;112:930-934.
97. Medoff BD, Sauty A, Tager AM, Maclean JA, Smith RN, Mathew A, Dufour JH, Luster AD: IFN-gamma-inducible protein 10 (CXCL10) contributes to airway hyperreactivity and airway inflammation in a mouse model of asthma. J Immunol 2002;168:5278-5286.
98. Proost P, Vynckier AK, Mahieu F, Put W, Grillet B, Struyf S, Wuyts A, Opdenakker G, Van Damme J: Microbial Toll-like receptor ligands differentially regulate CXCL10/IP-10 expression in fibroblasts and mononuclear leukocytes in synergy with IFN-gamma and provide a mechanism for enhanced synovial chemokine levels in septic arthritis. Eur J Immunol 2003;33:3146-3153.
99. Matsushima H, Yamada N, Matsue H, Shimada S: TLR3-, TLR7-, and TLR9-mediated production of proinflammatory cytokines and chemokines from murine connective tissue type skin-derived mast cells but not from bone marrow-derived mast cells. J Immunol 2004;173:531-541.
100. Rudd BD, Burstein E, Duckett CS, Li X, Lukacs NW: Differential role for TLR3 in respiratory syncytial virus-induced chemokine expression. J Virol 2005;79:3350-3357.
101. Maddox L, Schwartz DA: The pathophysiology of asthma. Annu Rev Med 2002;53:477-498.
102. Hartert TV, Peebles RS: Epidemiology of asthma: the year in review. Curr Opin Pulm Med 2000;6:4-9.
103. Arruda LK, Chapman MD: The role of cockroach allergens in asthma. Curr Opin Pulm Med 2001;7:14-19.
104. Baumholtz MA, Parish LC, Witkowski JA, Nutting WB: The medical importance of cockroaches. Int J Dermatol 1997;36:90-96.
105. Rosenstreich DL, Eggleston P, Kattan M, Baker D, Slavin RG, Gergen P, Mitchell H, McNiff-Mortimer K, Lynn H, Ownby D, Malveaux F: The role of cockroach allergy and exposure to cockroach allergen in causing morbidity among inner-city children with asthma. N Engl J Med 1997;336:1356-1363.
106. Cohn L, Ray A: T-helper type 2 cell-directed therapy for asthma. Pharmacol Ther 2000;88:187-196.
107. Barnes PJ: Th2 cytokines and asthma: an introduction. Respir Res 2001;2:64-65.
108. Robinson DS: Th-2 cytokines in allergic disease. Br Med Bull 2000;56:956-968.
109. Lee SY, Kim SJ, Kwon SS, Kim YK, Kim KH, Moon HS, Song JS, Park SH: Distribution and cytokine production of CD4 and CD8 T-lymphocyte subsets in patients with acute asthma attacks. Ann Allergy Asthma Immunol 2001;86:659-664.
110. O'Sullivan S, Cormican L, Faul JL, Ichinohe S, Johnston SL, Burke CM, Poulter LW: Activated, cytotoxic CD8(+) T lymphocytes contribute to the pathology of asthma death. Am J Respir Crit Care Med 2001;164:560-564.
111. Schwarze J, Makela M, Cieslewicz G, Dakhama A, Lahn M, Ikemura T, Joetham A, Gelfand EW: Transfer of the enhancing effect of respiratory syncytial virus infection on subsequent allergic airway sensitization by T lymphocytes. J Immunol 1999;163:5729-5734.
112. Braciale TJ: Respiratory syncytial virus and T cells: interplay between the virus and the host adaptive immune system. Proc Am Thorac Soc 2005;2:141-146.
113. Schaller MA, Lundy SK, Huffnagle GB, Lukacs NW: CD8(+) T cell contributions to allergen induced pulmonary inflammation and airway hyperreactivity. Eur J Immunol 2005;35:2061-2070.
114. Dakhama A, Park JW, Taube C, Joetham A, Balhorn A, Miyahara N, Takeda K, Gelfand EW: The enhancement or prevention of airway hyperresponsiveness during reinfection with respiratory syncytial virus is critically dependent on the age at first infection and IL-13 production. J Immunol 2005;175:1876-1883.
115. Stanciu LA, Shute J, Promwong C, Holgate ST, Djukanovic R: Increased levels of IL-4 in CD8+ T cells in atopic asthma. J Allergy Clin Immunol 1997;100:373-378.
116. Erb KJ, Le Gros G: The role of Th2 type CD4+ T cells and Th2 type CD8+ T cells in asthma. Immunol Cell Biol 1996;74:206-208.
117. Folkard SG, Westwick J, Millar AB: Production of interleukin-8, RANTES and MCP-1 in intrinsic and extrinsic asthmatics. Eur Respir J 1997;10:2097-2104.
118. Alam R, York J, Boyars M, Stafford S, Grant JA, Lee J, Forsythe P, Sim T, Ida N: Increased MCP-1, RANTES, and MIP-1alpha in bronchoalveolar lavage fluid of allergic asthmatic patients. Am J Respir Crit Care Med 1996;153:1398-1404.
119. Holgate ST, Bodey KS, Janezic A, Frew AJ, Kaplan AP, Teran LM: Release of RANTES, MIP-1 alpha, and MCP-1 into asthmatic airways following endobronchial allergen challenge. Am J Respir Crit Care Med 1997;156:1377-1383.
120. Blease K, Mehrad B, Standiford TJ, Lukacs NW, Kunkel SL, Chensue SW, Lu B, Gerard CJ, Hogaboam CM: Airway remodeling is absent in CCR1-/- mice during chronic fungal allergic airway disease. J Immunol 2000;165:1564-1572.
121. Ma B, Zhu Z, Homer RJ, Gerard C, Strieter R, Elias JA: The C10/CCL6 chemokine and CCR1 play critical roles in the pathogenesis of IL-13-induced inflammation and remodeling. J Immunol 2004;172:1872-1881.